8-K: Functional Brands Q2 2026: Wider Loss, Delisting Impact

Functional Brands Inc. reported a widened operating and net loss for Q2 2026, alongside a going concern warning and the delisting of its stock from Nasdaq.

Summary

• Functional Brands Inc. announced its financial results for the second quarter ended June 30, 2026.
• Revenue increased by 2% to $1.87 million, up from $1.83 million in the prior year period.
• Gross profit rose to $1.12 million, with gross margin improving to 59.9% from approximately 52.8% in the prior year.
• Operating loss significantly widened to $1.3 million from $0.16 million in the prior year period.
• Net loss for the quarter was $2.6 million, compared to a net loss of $0.2 million in the prior year period.
• For the six months ended June 30, 2026, net loss was $9.6 million, including a $6.3 million non-cash charge related to a preferred stock exchange.
• The company's cash balance was $352,142 as of June 30, 2026, with a working capital deficit of $2.9 million.
• Substantial doubt exists about the company's ability to continue as a going concern.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to significant increases in operating losses and net loss, coupled with a going concern warning and the stock's delisting from Nasdaq.

Positives

• Revenue grew by 2% to $1.87 million, driven by direct-to-consumer sales and contract manufacturing.
• Gross profit increased by approximately 16% to $1.12 million.
• Gross margin improved significantly by 710 basis points to 59.9%, attributed to a shift towards higher-margin channels and the Amazon business model transition.
• The company received a judgment largely in its favor in a previously disclosed litigation, with only a minor award against a related entity.

Negatives

• Operating loss widened substantially to $1.3 million from $0.16 million in the prior year's second quarter.
• Net loss increased significantly to $2.6 million from $0.2 million in the prior year's second quarter.
• The company's common stock was delisted from The Nasdaq Stock Market and began trading on OTC Markets.
• The termination of the BullionFX letter of intent for the acquisition of blockchain-related IP and assets.
• Cash balance stood at $352,142 as of June 30, 2026, with a working capital deficit of $2,903,380.
• The company has an accumulated deficit of $16,679,712.
• Substantial doubt exists about the company's ability to continue as a going concern.

Risks

• The company's ability to continue as a going concern due to recurring losses and cash used in operations.
• The need to secure additional financing through debt and equity, with no assurance of success.
• The impact of the common stock trading on OTC Markets, potentially affecting liquidity and capital raising ability.
• The outcome of pending legal proceedings and potential appeals.
• The company's continued reliance on existing operations and available cash resources following the termination of the BullionFX letter of intent.

Future Outlook

Management's focus is on strengthening the balance sheet, managing the cost structure, and executing on the core nutraceutical business. The company believes existing cash, future capital raises, and product sales will be necessary to fund ongoing operations, but there is no assurance of securing additional financing.

Management Comments

• "Our core Kirkman business continued to make real progress in the second quarter revenue grew and gross margin expanded meaningfully and we believe that underlying momentum is genuine."
• "At the same time, we want our stockholders to have a clear picture of the challenges we are managing: the termination of the BullionFX letter of intent, our common stocks move to OTC Markets, and the increased costs of operating as a public company all weighed on our results this quarter."
• "Our focus now is on strengthening our balance sheet, managing our cost structure, and executing on the core nutraceutical business that remains the foundation of this Company."

Industry Context

StockSavvy.ai notes that the wellness and performance products industry is competitive, with companies often facing challenges in scaling operations, managing costs, and navigating public market requirements. Functional Brands' shift to OTC Markets and increased public-company related expenses are common pressures for smaller public entities.

Legal Proceedings

• Litigation brought by True Health Medical Center, S.C. resulted in a judgment largely in favor of Functional Brands Inc. and the HTO Parties, with True Health awarded $68,271 against Kirkman Group, Inc. on a narrow claim, while all other counts were rejected.

Stakeholder Impact

• Shareholders: Potential dilution from future capital raises, impact of stock delisting on liquidity and valuation.
• Creditors: Concerns regarding the company's ability to continue as a going concern may affect debt repayment.
• Employees: Uncertainty surrounding the company's financial stability could impact morale and job security.

Next Steps

• Strengthening the balance sheet.
• Managing the cost structure.
• Executing on the core nutraceutical business.

Key Dates

Recommendation

The significant increase in net loss, widening operating loss, substantial working capital deficit, and the explicit warning about the ability to continue as a going concern, combined with the delisting from Nasdaq, present considerable risks. While revenue and gross margin showed some improvement, these are overshadowed by the severe financial distress and operational challenges indicated in the filing.

Keywords

Functional Brands, Q2 2026 Results, Revenue Growth, Gross Margin Improvement, Operating Loss, Net Loss, Going Concern, OTC Markets